Back to School: How biopharma can reboot drug development. Access exclusive analysis here
In a 12-week, double-blind study in 334 patients, Cymbalta reduced pain compared with placebo
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury